Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches (Q39428933)

11 September 2017

title

Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches (English)

1 reference

11 September 2017

main subject

neoplastic stem cells

1 reference

Dong Fang

1

1 reference

11 September 2017

Hiroshi Kitamura

series ordinal

2

1 reference

11 September 2017

publication date

11 July 2017

1 reference

International Journal of Urology

11 September 2017

published in

1 reference

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

11 September 2017

cites work

1 reference

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

21 January 2018

1 reference

Cancer stem cells: problems for therapy?

21 January 2018

1 reference

Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma

21 January 2018

1 reference

Cancer stem cells and cancer therapy

21 January 2018

1 reference

Hit 'em where they live: targeting the cancer stem cell niche

21 January 2018

1 reference

Tumour stem cells and drug resistance

21 January 2018

1 reference

21 January 2018

Cancer statistics, 1998

1 reference

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

21 January 2018

1 reference

The route to personalized medicine in bladder cancer: where do we stand?

21 January 2018

1 reference

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

21 January 2018

1 reference

Emerging role of immunotherapy in urothelial carcinoma-Advanced disease

21 January 2018

1 reference

Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations

21 January 2018

1 reference

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

21 January 2018

1 reference

Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

21 January 2018

1 reference

Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives

21 January 2018

1 reference

Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.

21 January 2018

1 reference

Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells

21 January 2018

1 reference

Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway

21 January 2018

1 reference

Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling

21 January 2018

1 reference

2-cyclohexylamino-5,8-dimethoxy-1,4-naphthoquinone inhibits LPS-induced BV2 microglial activation through MAPK/NF-kB signaling pathways

21 January 2018

1 reference

A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells

21 January 2018

1 reference

Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway

21 January 2018

1 reference

MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B

21 January 2018

1 reference

Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer

21 January 2018

1 reference

Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.

21 January 2018

1 reference

The stem cell self-renewal gene, Musashi 1, is highly expressed in tumor and non-tumor samples of human bladder.

21 January 2018

1 reference

Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells.

21 January 2018

1 reference

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

21 January 2018

1 reference

Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer

21 January 2018

1 reference

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

Cancer stem cell-like characteristics of a CD133( ) subpopulation in the J82 human bladder cancer cell line

21 January 2018

1 reference

Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome

21 January 2018

1 reference

Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells

21 January 2018

1 reference

Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas

21 January 2018

1 reference

Epithelial plasticity in urothelial carcinoma: Current advancements and future challenges

21 January 2018

1 reference

Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity

21 January 2018

1 reference

CD26 a cancer stem cell marker and therapeutic target.

21 January 2018

1 reference

Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx.

21 January 2018

1 reference

Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.

21 January 2018

1 reference

CD44: from adhesion molecules to signalling regulators

21 January 2018

1 reference

Osteopontin: role in cell signaling and cancer progression

21 January 2018

1 reference

Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer

21 January 2018

1 reference

Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer.

21 January 2018

1 reference

Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.

21 January 2018

1 reference

Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target

21 January 2018

1 reference

Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches

21 January 2018

1 reference

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo

21 January 2018

1 reference

Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer

21 January 2018

1 reference

Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract

21 January 2018

1 reference

Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.

21 January 2018

1 reference

21 January 2018

Twenty Sox, twenty years

1 reference

All purpose Sox: The many roles of Sox proteins in gene expression

21 January 2018

1 reference

Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.

21 January 2018

1 reference

Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent

21 January 2018

1 reference

Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming

21 January 2018

1 reference

Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder

21 January 2018

1 reference

Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma

21 January 2018

1 reference

Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer

21 January 2018

1 reference

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

Genetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk

21 January 2018

1 reference

IRE1α-XBP1 signaling pathway, a potential therapeutic target in multiple myeloma

21 January 2018

1 reference

Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.

21 January 2018

1 reference

Canonical Notch signalling is inactive in urothelial carcinoma.

21 January 2018

1 reference

A new tumor suppressor role for the Notch pathway in bladder cancer

21 January 2018

1 reference

NOTCH pathway inactivation promotes bladder cancer progression

21 January 2018

1 reference

Role of aberrant PI3K pathway activation in gallbladder tumorigenesis

21 January 2018

1 reference

Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis

21 January 2018

1 reference

A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition

21 January 2018

1 reference

Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis

21 January 2018

1 reference

TGF-β signaling in fibrosis

21 January 2018

1 reference

The regulation of TGFbeta signal transduction

21 January 2018

1 reference

Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model

21 January 2018

1 reference

EMT or apoptosis: a decision for TGF-beta

21 January 2018

1 reference

Reprogramming during epithelial to mesenchymal transition under the control of TGFβ

21 January 2018

1 reference

TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12.

21 January 2018

1 reference

MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.

21 January 2018

1 reference

MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.

21 January 2018

1 reference

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

21 January 2018

1 reference

The role of microRNAs in bladder cancer

21 January 2018

1 reference

MicroRNA Regulation of Epithelial to Mesenchymal Transition

21 January 2018

1 reference

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

21 January 2018

1 reference

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

Stem cell regulation by polycomb repressors: postponing commitment

21 January 2018

1 reference

Linkage between Twist1 and Bmi1: Molecular mechanism of cancer metastasis/stemness and clinical implications

21 January 2018

1 reference

Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene

21 January 2018

1 reference

Polycombing the genome: PcG, trxG, and chromatin silencing

21 January 2018

1 reference

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

Expression of Bmi-1 is a prognostic marker in bladder cancer

21 January 2018

1 reference

Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

21 January 2018

1 reference

Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer

21 January 2018

1 reference

Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells

21 January 2018

1 reference

Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2

21 January 2018

1 reference

EZH2 in Bladder Cancer, a Promising Therapeutic Target

21 January 2018

1 reference

Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors

21 January 2018

1 reference

Immunotherapy for the Treatment of Urothelial Carcinoma

21 January 2018

1 reference

Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma.

21 January 2018

1 reference

Cancer testis antigen and immunotherapy

21 January 2018

1 reference

Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine

21 January 2018

1 reference

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway

21 January 2018

1 reference

Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells

21 January 2018

1 reference

Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer

21 January 2018

1 reference

Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation

21 January 2018

1 reference

Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.

21 January 2018

1 reference

Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways

21 January 2018

1 reference

Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity

21 January 2018

1 reference

Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition

21 January 2018

1 reference

The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor

21 January 2018

1 reference

Cofactor of BRCA1 modulates androgen-dependent transcription and alternative splicing

21 January 2018

1 reference

The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer

21 January 2018

1 reference

Role of autophagy in cancer

21 January 2018

1 reference

The double-edged sword of autophagy modulation in cancer

21 January 2018

1 reference

Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine

21 January 2018

1 reference

Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells

21 January 2018

1 reference

Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer

21 January 2018

1 reference

Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells

21 January 2018

1 reference

JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IJU.13404

1 reference

11 September 2017

1 reference